Publication | Open Access
Methicillin resistance in <i>Staphylococcus</i> <i>aureus</i> requires glycosylated wall teichoic acids
292
Citations
38
References
2012
Year
Bioorganic ChemistryGlycobiologyS. Aureus WtasPolysaccharideAntibiotic ResistanceBacterial PathogensDrug ResistanceMrsa ResistanceInfection ControlWta BackboneAntimicrobial ResistanceHealth SciencesGlycosylationAntimicrobial Drug DiscoveryBiochemistryWall Teichoic AcidsAntimicrobial CompoundBacterial ResistanceClinical MicrobiologyAntimicrobial Resistance GeneAntimicrobial SusceptibilityAntibioticsMicrobiologyMedicineCarbohydrate-protein Interaction
Staphylococcus aureus peptidoglycan (PG) is densely functionalized with anionic polymers called wall teichoic acids (WTAs). These polymers contain three tailoring modifications: d-alanylation, α-O-GlcNAcylation, and β-O-GlcNAcylation. Here we describe the discovery and biochemical characterization of a unique glycosyltransferase, TarS, that attaches β-O-GlcNAc (β-O-N-acetyl-D-glucosamine) residues to S. aureus WTAs. We report that methicillin resistant S. aureus (MRSA) is sensitized to β-lactams upon tarS deletion. Unlike strains completely lacking WTAs, which are also sensitive to β-lactams, ΔtarS strains have no growth or cell division defects. Because neither α-O-GlcNAc nor β-O-Glucose modifications can confer resistance, the resistance phenotype requires a highly specific chemical modification of the WTA backbone, β-O-GlcNAc residues. These data suggest β-O-GlcNAcylated WTAs scaffold factors required for MRSA resistance. The β-O-GlcNAc transferase identified here, TarS, is a unique target for antimicrobials that sensitize MRSA to β-lactams.
| Year | Citations | |
|---|---|---|
Page 1
Page 1